Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
anti-CXCL13/BLC/BCA-1, APC, Clone: 53610, R&D Systems™
Mouse Monoclonal Antibody has been used in 3 publications
Supplier: R&D Systems IC801A
This item is not returnable.
View return policy
Description
CXCL13/BLC/BCA-1 Monoclonal specifically detects CXCL13/BLC/BCA-1 in Human samples. It is validated for Intracellular Staining by Flow Cytometry.Specifications
CXCL13/BLC/BCA-1 | |
Monoclonal | |
APC | |
Supplied in a saline solution containing BSA and Sodium Azide. with Sodium Azide | |
ANGIE, ANGIE2, B cell-attracting chemokine 1, B lymphocyte chemoattractant, BCA1, BCA-1, BCA1B-cell chemoattractant, BCA-1CXC chemokine BLC, B-cell-homing chemokine (ligand for Burkitt's lymphoma receptor-1), BLC, BLCSmall-inducible cytokine B13, BLR1L, B-lymphocyte chemoattractant, chemokine (C-X-C motif) ligand 13, chemokine (C-X-C motif) ligand 13 (B-cell chemoattractant), C-X-C motif chemokine 13, SCYB13, SCYB13B-cell-attracting chemokine 1, small inducible cytokine B subfamily (Cys-X-Cys motif), member 13 (B-cellchemoattractant) | |
Mouse | |
Protein A or G purified from hybridoma culture supernatant | |
RUO | |
10563 | |
Human | |
Purified |
Flow Cytometry | |
53610 | |
Intracellular Staining by Flow Cytometry 10 uL/10^6 cells | |
O43927 | |
CXCL13 | |
E. coli-derived recombinant human CXCL13/BLC/BCA-1 Val23-Arg94 Accession # O43927 | |
100 Tests | |
Primary | |
Detects human CXCL13/BLC/BCA-1 in ELISAs and Western blots. In ELISAs, this antibody does not cross-react with recombinant human (rh) CXCL1, rhCXCL2, rhCXCL3, rhCXCL8/IL-8, rhCXCL10, rhCXCL9, rhCXCL12/SDF-1 alpha , or rhCXCL12/SDF-1 beta . | |
Protect from light. Do not freeze. 12 months from date of receipt, 2 to 8 degreesC as supplied. | |
IgG1 |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction